FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the pharmaceutical industry, specifically to a liquid antacid composition. Liquid antacid composition containing: antacid; citrus extract; and optionally one or more other pharmaceutically acceptable excipients; where the citrus extract is present in amount of 0.025 % to 1.90 % and where the citrus extract is a water-soluble extract of citrus fruit selected from citrus aurantium amara (CAS 72968-50-4), citrus reticulata (CAS No. 84929-38-4) and citrus sinensis (CAS 8028-48-6). Use of a liquid antacid composition for neutralizing an excess of gastric acid in an individual or a lower animal, involving oral administration of an effective amount of a liquid antacid composition to said human or lower animal. Use of a liquid antacid composition for treating a gastrointestinal disorder in a human or a lower animal, comprising administering to said human or lower animal an effective amount of a liquid antacid composition. Composition described above provides excellent resistance to growth of microorganisms without detriment to acid neutralizing activity of the antacid; the composition has an improved taste.
EFFECT: when using said composition there is no increase on 14th and 28th days relative to the initial counted number for bacteria, yeast and mould.
13 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
USE OF ORGANIC CITRUS EXTRACT WITH HIGH ANTIMICROBIAL CAPACITY AND XYLITOL AS PRESERVATIVE SYSTEM IN LIQUIDS, EMULSIONS, SUSPENSIONS, CREAMS AND ANTACIDS | 2016 |
|
RU2715906C2 |
LIQUID ORAL PHARMACEUTICAL DOSAGE FORM CONTAINING HISTAMINE H2-RECEPTOR ANTAGONIST AND ANTACID | 2017 |
|
RU2761346C2 |
LIQUID ORAL PHARMACEUTICAL DOSAGE FORM | 2019 |
|
RU2810115C2 |
LIQUID ORAL PHARMACEUTICAL DOSAGE FORM | 2019 |
|
RU2783413C2 |
THERMOSTABLE ANTIACID SUSPENSION | 1999 |
|
RU2223092C2 |
LIQUID ANTIACID COMPOSITIONS | 1998 |
|
RU2193889C2 |
LIQUID ANTACID COMPOSITIONS | 2003 |
|
RU2322246C2 |
COMPOSITIONS AND METHODS FOR ENHANCING TOPICAL APPLICATION OF ACIDIC BENEFIT AGENT | 2015 |
|
RU2683779C2 |
NEW IMPROVED RACECADOTRIL COMPOSITION | 2017 |
|
RU2745888C2 |
NEW IMPROVED COMPOSITION CONTAINING AT LEAST ONE CADOTRIL | 2017 |
|
RU2751772C2 |
Authors
Dates
2020-02-20—Published
2016-05-26—Filed